Biblio

Found 24 results

Filters: Keyword is Ovarian Neoplasms [Clear All Filters]

2015

Armaiz-Pena GN, Gonzalez-Villasana V, Nagaraja AS, Rodriguez-Aguayo C, Sadaoui NC, Stone RL, Matsuo K, Dalton HJ, Previs RA, Jennings NB et al.. 2015. Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth.. Oncotarget. 6(6):4266-73.

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM et al.. 2015. Diurnal cortisol and survival in epithelial ovarian cancer.. Psychoneuroendocrinology. 53:256-67.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM et al.. 2015. Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.. Cancer. 121(19):3543-50.

2014

Carpenter KM, Eisenberg S, Weltfreid S, Low CA, Beran T, Stanton AL. 2014. Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery.. Health Psychol. 33(9):1003-11.

2013

Moreno-Smith M, Lee SJoo, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HDong, Jennings NB, Roh J-W, Nishimura M et al.. 2013. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.. Neoplasia. 15(5):502-10.

Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA et al.. 2013. Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.. Brain Behav Immun. 30 Suppl:S126-34.

Lutgendorf SK, Slavich GM, Degeest K, Goodheart M, Bender D, Thaker PH, Penedo F, Zimmerman B, Lucci J, Mendez L et al.. 2013. Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients.. Gynecol Oncol. 131(3):667-73.

Clevenger L, Schrepf A, Degeest K, Bender D, Goodheart M, Ahmed A, Dahmoush L, Penedo F, Lucci J, Thaker PH et al.. 2013. Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis.. Cancer. 119(17):3234-41.

2012

Lutgendorf SK, De Geest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, M Zimmerman B, Penedo FJ, Lucci JA, Ganjei-Azar P et al.. 2012. Social influences on clinical outcomes of patients with ovarian cancer.. J Clin Oncol. 30(23):2885-90.

2011

Moreno-Smith M, Lu C, Shahzad MMK, Pena GNArmaiz, Allen JK, Stone RL, Mangala LS, Han HDong, Kim HSun, Farley D et al.. 2011. Dopamine blocks stress-mediated ovarian carcinoma growth.. Clin Cancer Res. 17(11):3649-59.

Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G et al.. 2011. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.. Brain Behav Immun. 25(2):250-5.

2010

Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, Carroll AR, Spannuth WA, Deavers MT, Allen JK et al.. 2010. Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis.. J Clin Invest. 120(5):1515-23.

Shahzad MMK, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee J-W, Jennings NB, Bottsford-Miller J et al.. 2010. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.. J Biol Chem. 285(46):35462-70.

2009

Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci J, Goodheart M, Lubaroff D, Farley DM, Sood AK et al.. 2009. Depression, social support, and beta-adrenergic transcription control in human ovarian cancer.. Brain Behav Immun. 23(2):176-83.

Armaiz-Pena GN, Mangala LS, Spannuth WA, Lin YG, Jennings NB, Nick AM, Langley RR, Schmandt R, Lutgendorf SK, Cole SW et al.. 2009. Estrous cycle modulates ovarian carcinoma growth.. Clin Cancer Res. 15(9):2971-8.

Lee J-W, Shahzad MMK, Lin YG, Armaiz-Pena G, Mangala LS, Han H-D, Kim H-S, Nam EJi, Jennings NB, Halder J et al.. 2009. Surgical stress promotes tumor growth in ovarian carcinoma.. Clin Cancer Res. 15(8):2695-702.

2008

Low CA, Bower JE, Kwan L, Seldon J. 2008. Benefit finding in response to BRCA1/2 testing.. Ann Behav Med. 35(1):61-9.

Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JMG, Penedo F, DeGeest K, Langley RR, Lucci JA, Cole SW, Lubaroff DM et al.. 2008. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.. Clin Cancer Res. 14(21):6839-46.

2007

Landen CN, Lin YG, Pena GNArmaiz, Das PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH et al.. 2007. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.. Cancer Res. 67(21):10389-96.

Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE et al.. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.. J Biol Chem. 282(41):29919-26.

2006

Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M et al.. 2006. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.. Nat Med. 12(8):939-44.

Halder J, Kamat AA, Landen CN, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL et al.. 2006. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.. Clin Cancer Res. 12(16):4916-24.

Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, Thaker PH, Li Y, Gershenson DM, Lutgendorf S, Cole SW. 2006. Stress hormone-mediated invasion of ovarian cancer cells.. Clin Cancer Res. 12(2):369-75.

2003

Lutgendorf SK, Cole S, Costanzo E, Bradley S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M, Sood AK. 2003. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.. Clin Cancer Res. 9(12):4514-21.